Skip to main content
. 2020 Aug 6;2020(8):CD008227. doi: 10.1002/14651858.CD008227.pub4

Patchell 1999.

Study characteristics
Methods Prospective, randomized, open‐label, cross‐over trial.
Duration: treatment was for a period of 10 weeks; 2‐week run‐in, followed by randomization to 1 of the 2 arms for 4 weeks, and then cross over to alternative treatment for the next 4 weeks.
Multicentre trial at 3 hospitals in the UK.
Participants 59 children with CF, diagnosed by 2 sweat tests or genotype, had proven pancreatic insufficiency.
Age: mean (SD) age of 10 (3.5) years.
Gender split: not given.
Interventions Group 1: ECM (Creon 8000 MS®).
Group 2: ECMM (Creon 10000 MMS ®).
Dose was lipase for lipase. The median intake of lipase/kg body weight/day was 6689 for Creon 8000® and 8527 for Creon 10000 ®.
Outcomes FFE, CFA, stool frequency, abdominal pain, participant preference.
Notes The stool collection for CFA was done only in 1 centre, with 22 participants.
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Unclear risk Described as randomized, further information not given.
Allocation concealment (selection bias) Unclear risk Information not given.
Blinding of participants and personnel (performance bias)
Participants High risk No blinding.
Blinding of participants and personnel (performance bias)
Clinicians High risk No blinding.
Blinding of outcome assessment (detection bias)
All outcomes High risk No blinding.
Incomplete outcome data (attrition bias)
All outcomes Low risk Stool collection data were from 1 hospital only with 22 participants in an intent‐to‐treat analysis.
54 participants completed the trial, 2 dropped out in run‐in period due to abdominal pain and loose stools; a further 2 dropped out during the ECMM phase (1 due to abdominal pain and loose stools and 1 due to meconium ileus equivalent). The 5th participant dropped out during the ECMM phase due to an appendix abscess considered to be unrelated to treatment.
Selective reporting (reporting bias) High risk Data on stool frequency and abdominal pain reported in a way that could not be included in the analysis.
Other bias Low risk Study appears to be free of other sources of bias.